Furthermore, we found that DIO significantly increases mammary tumor growth, induces a more aggressive pathology, and represses tumoral p53 and p21 protein expression in both Wnt-1 p53+/+ and Wnt-1 p53+/− tumors (Figure 5). The gene discussed is TP53; the disease is breast cancer.